NM
Molnarfi, Nicolas
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| In-vivo gp100-specific Cytotoxic CD8+ T Cell Killing Assay | Bio-protocol |  | 2018 | 306 | 253 | ||
| Phenotypes, Origins and Functions of Regulatory B Cells in Autoimmune and Inflammatory Diseases | | 2018 | 636 | 83 | |||
| Activation of human B cells negatively regulates TGF-β1 production | Journal of Neuroinflammation | | 2017 | 586 | 241 | ||
| Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes | EMBO Reports |  | 2017 | 591 | 4 | ||
| B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation | Scientific reports | | 2016 | 620 | 247 | ||
| Hepatocyte growth factor: A regulator of inflammation and autoimmunity | Autoimmunity reviews | | 2015 | 555 | 0 | ||
| Glatiramer acetate treatment negatively regulates type I interferon signaling | Neurology® neuroimmunology & neuroinflammation | | 2015 | 472 | 1 | ||
| The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells | Journal of neuroimmunology | | 2014 | 542 | 0 | ||
| Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells | The Journal of immunology | | 2014 | 691 | 3 | ||
| MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies | The Journal of experimental medicine | | 2013 | 245 | 99 | ||
| Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases | PloS one | | 2013 | 749 | 465 | ||
| The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity | Journal of neuroinflammation | | 2013 | 624 | 350 | ||
| IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis | Journal of neuroinflammation | | 2012 | 719 | 325 | ||
| Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients | PloS one | | 2012 | 680 | 255 | ||
| Antibody response in MOG35–55 induced EAE | Journal of neuroimmunology | | 2011 | 756 | 685 | ||
| A novel MEK2/PI3Kdelta pathway controls the expression of IL-1 receptor antagonist in IFN-beta-activated human monocytes | Journal of leukocyte biology | | 2010 | 555 | 1 | ||
| Glatiramer acetate triggers PI3Kdelta/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes | Proceedings of the National Academy of Sciences of the United States of America | | 2010 | 699 | 0 | ||
| Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis | Proceedings of the National Academy of Sciences of the United States of America | | 2009 | 637 | 0 | ||
| Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins | Journal of leukocyte biology | | 2008 | 656 | 0 | ||
| IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes | International immunology | | 2008 | 571 | 164 | ||
| Differential regulation of cytokine production by PI3Kdelta in human monocytes upon acute and chronic inflammatory conditions | Molecular immunology | | 2008 | 614 | 0 | ||
| Production of pro- and anti-inflammatory cytokines in human monocytes : regulation and signaling | | 2005 | 1,484 | 1,417 |
